Ivan Padjen

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Decision Making

Respiratory Syndrome Coronavirus

Systemic Lupus Erythematosus

Top Venues

Rheumatology international

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Sandra Karanović Štambuk, Ivan Padjen, Nikolina Bašić Jukić, Jadranka Šeparović Hanževački, Branimir Anić
Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption. Clinical rheumatology (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international 44 (2) (2023)
Sandra Karanović Štambuk, Ivan Padjen, Nikolina Bašić Jukić, Jadranka Šeparović Hanževački, Branimir Anić
Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption. Clinical rheumatology 42 (6) (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international 44 (2) (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international 44 (2) (2023)
Sandra Karanović Štambuk, Ivan Padjen, Nikolina Bašić Jukić, Jadranka Šeparović Hanževački, Branimir Anić
Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption. Clinical rheumatology 42 (6) (2023)
Elena Primorac Padjen, Robert Marcec, Matija Zidar, Ivan Padjen, Tomislav Katanec, Branimir Anić, Robert Likić
Comparison of reporting rates of arthritis and arthralgia following AstraZeneca, Pfizer-BioNTech, Moderna, and Janssen vaccine administration against SARS-CoV-2 in 2021: analysis of European pharmacovigilance large-scale data. Rheumatology international (2023)
Sandra Karanović Štambuk, Ivan Padjen, Nikolina Bašić Jukić, Jadranka Šeparović Hanževački, Branimir Anić
Rescue treatment of severe lupus myocarditis and proliferative lupus nephritis with immunoadsorption. Clinical rheumatology (2023)
Alessia Alunno, Ivan Padjen, Antonis Fanouriakis, Dimitrios T Boumpas
Pathogenic and Therapeutic Relevance of JAK/STAT Signaling in Systemic Lupus Erythematosus: Integration of Distinct Inflammatory Pathways and the Prospect of Their Inhibition with an Oral Agent. Cells 8 (8) (2019)